Skip to main content
. Author manuscript; available in PMC: 2021 May 26.
Published in final edited form as: Lancet. 2020 Apr 18;395(10232):1278–1291. doi: 10.1016/S0140-6736(20)30262-2

Figure 4: Kaplan–Meier curves of independent review committee–assessed progression-free survival for patients with high-risk genomic features and high-risk features.

Figure 4:

Figure 4:

(A) Del(17)(p13·1). (B) Del(11)(q22·3). (C) Cellular tumour antigen p53 gene mutation. (D) Unmutated immunoglobulin heavy-chain variable gene. (E) Bulky disease.